Securing capital in life sciences isn’t just about a strong innovation—it’s about navigating long timelines, regulatory complexity, and investor expectations that go far beyond the pitch deck.
Join investors and advisors who are actively deploying capital and structuring deals across North America: Lu Han (Lumira Ventures), Judyanna Yu (One Six 8 Ventures), and Adam Falconi (Mintz LLP), moderated by Jason Ding (Deloitte).
This panel will unpack how investment decisions actually get made—what signals readiness, what raises concern, and what separates fundable companies from the rest.
Expect a candid discussion on diligence, deal dynamics, and what “smart money” really looks like in practice—including how the right investor can shape your company’s trajectory long after the cheque is written.
Designed for founders and operators building in life sciences who are preparing to raise, currently fundraising, or thinking about their next stage of growth.
Event Flow
7:30 AM | Doors Open, registration & networking
8:00 AM | Panel discussion & Q&A
Lu Han, Ph.D., Partner — Lumira Ventures
Judyanna Yu, Managing Partner — One Six 8 Ventures
Adam Falconi, Associate — Mintz
Moderator: Jason Ding, FCPA, FCA — Deloitte
9:00 AM | Networking & Breakfast
This session is curated to ensure the right mix of founders, investors, and advisors in the room. As a life sciences-focused event, alignment matters—an application process helps us create high-value conversations and meaningful connections for everyone involved.
This event is hosted by Edmonton Unlimited.